Related Experiment Videos
Inhibitory effect of human atrial natriuretic peptide on cyclic AMP levels in microdissected human glomeruli
1Second Department of Internal Medicine, Yokohama City University School of Medicine, Japan.
Insights
Alpha-human atrial natriuretic peptide (alpha-hANP) regulates cyclic AMP (cAMP) in human glomeruli. This peptide inhibits cAMP increases induced by parathyroid hormone (PTH), potentially impacting glomerular filtration rate (GFR).
Area of Science:
- Nephrology
- Endocrinology
- Molecular Biology
Background:
- Decreased cyclic AMP (cAMP) in glomeruli may elevate glomerular filtration rate (GFR) by increasing the glomerular capillary ultrafiltration coefficient (kf).
- Alpha-human atrial natriuretic peptide (alpha-hANP) is investigated for its role in regulating renal cAMP levels.
Purpose of the Study:
- To determine if alpha-hANP can regulate cyclic AMP (cAMP) levels in human glomeruli.
- To explore the potential impact of alpha-hANP on glomerular filtration rate (GFR) through cAMP modulation.
Main Methods:
- Human renal cortical tissues were obtained and glomeruli were isolated.
- Glomeruli were incubated with parathyroid hormone (PTH) and/or alpha-hANP.
- Cyclic AMP (cAMP) levels were quantified using radioimmunoassay.
Main Results:
- Alpha-hANP alone did not affect basal glomerular cAMP levels.
- Parathyroid hormone (PTH) stimulated cAMP formation in a dose-dependent manner.
- Alpha-hANP significantly inhibited PTH-induced cAMP accumulation by up to 50% in a dose-dependent manner.
Conclusions:
- Alpha-hANP modulates cAMP production in human glomeruli.
- The inhibitory effect of alpha-hANP on PTH-stimulated cAMP suggests a mechanism for increasing GFR.
- Alpha-hANP may play a role in regulating kidney function by influencing glomerular hemodynamics via cAMP signaling.
Abstract:
We studied whether alpha-human atrial natriuretic peptide (alpha-hANP) had the capacity to regulate cyclic AMP (cAMP) levels in human glomeruli, since decreased cAMP in the glomerulus may increase the glomerular filtration rate (GFR) through increasing kf (glomerular capillary ultrafiltration coefficient). Human kidneys were obtained at surgery for carcinoma. Normal cortical tissues from these kidneys were used for the study. After incubating the renal cortical slices with 0.1% collagenase, glomeruli were dissected manually under the stereomicroscope. Two glomeruli were incubated (37 degrees C, 2 min) with parathyroid hormone (PTH) and/or alpha-hANP. cAMP was determined by radioimmunoassay. alpha-hANP at a concentration of 5 x 10(-6) M had no effect on glomerular cAMP accumulation in the basal condition. PTH stimulated cAMP formation in a dose-dependent manner. alpha-hANP inhibited significantly the increase in cAMP formation induced by PTH (p less than 0.01). This action of alpha-hANP was dose-dependent, with a maximum of 50% inhibition. PTH is one of the endogenous substances that are known to increase cAMP formation and decrease kf. Thus, it seems likely that alpha-hANP increased GFR through modulating the production of cAMP in human kidney.